Phenotypic and genotypic characterization of group B streptococcal isolates in Southern Brazil

Journal of Clinical Microbiology

Volumn 48, Issue 12, 2010, Pages 4397-4403

  Palmeiro, Jussara K ^a,d   Dalla Costa, Libera M ^a   Fracalanzza, Sérgio E L ^b   Botelho, Ana C N ^b   Da Silva Nogueira, Keite ^a   Scheffer, Mara C ^a   De Almeida Torres, Rosângela S L ^c   De Carvalho, Newton Sérgio ^a   Cogo, Laura Lúcia ^a   Madeira, Humberto M F ^d  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Laboratory of Bacteriology   (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; PENICILLIN G; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; ERMA GENE; ERMB GENE; FEMALE; GENE CLUSTER; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPING; STREPTOCOCCUS AGALACTIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BRAZIL; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HOSPITALS; HUMANS; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PHENOTYPE; PREGNANCY; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

EID: 78650042230     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00419-10     Document Type: Article

References (58)

1. Amundson, N. R., A. E. Flores, S. L. Hillier, C. J. Baker, and P. Ferrieri. 2005. DNA macrorestriction analysis of nontypeable group B streptococcal isolates: clonal evolution of nontypeable and type V isolates. J. Clin. Microbiol. 43:572-576.
2. Andrews, J. I., D. J. Diekema, S. K. Hunter, P. R. Rhomberg, M. A. Pfaller, R. N. Jones, and G. V. Doern. 2000. Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am. J. Obstet. Gynecol. 183:859-862.
3. Benson, J. A., A. E. Flores, C. J. Baker, S. L. Hillier, and P. Ferrieri. 2002. Improved methods for typing nontypeable isolates of group B streptococci. Int. J. Med. Microbiol. 292:37-42.
4. Betriu, C., E. Culebras, M. Gomez, I. Rodriguez-Avial, B. A. Sanchez, M. C. Agreda, and J. J. Picazo. 2003. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob. Agents Chemother. 47:1112-1114.
5. Bliss, S. J., S. D. Manning, P. Tallman, C. J. Baker, M. D. Pearlman, C. F. Marrs, and B. Foxman. 2002. Group B Streptococcus colonization in male and nonpregnant female university students: a cross-sectional prevalence study. Clin. Infect. Dis. 34:184-190.
6. Borchardt, S. M., J. H. DeBusscher, P. A. Tallman, S. D. Manning, C. F. Marrs, T. A. Kurzynski, and B. Foxman. 2006. Frequency of antimicrobial resistance among invasive and colonizing Group B streptococcal isolates. BMC Infect. Dis. 6:57.
7. Chu, Y. W., C. Tse, G. K. Tsang, D. K. So, J. T. Fung, and J. Y. Lo. 2007. Invasive group B Streptococcus isolates showing reduced susceptibility to penicillin in Hong Kong. J. Antimicrob. Chemother. 60:1407-1409.
8. Cieslewicz, M. J., D. Chaffin, G. Glusman, D. Kasper, A. Madan, S. Rodrigues, J. Fahey, M. R. Wessels, and C. E. Rubens. 2005. Structural and genetic diversity of group B Streptococcus capsular polysaccharides. Infect. Immun. 73:3096-3103.
9. Clancy, J., J. Petitpas, F. Dib-Hajj, W. Yuan, M. Cronan, A. V. Kamath, J. Bergeron, and J. A. Retsema. 1996. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 22:867-879.
10. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial disk susceptibility tests; approved standard, 10th ed. CLSI document M2-A10. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed. CLSI document M7-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. CLSI document M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
13. Dahesh, S., M. E. Hensler, N. M. Van Sorge, R. E. Gertz, Jr., S. Schrag, V. Nizet, and B. W. Beall. 2008. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob. Agents Chemother. 52:2915-2918.
14. de Azavedo, J. C., R. H. Yeung, D. J. Bast, C. L. Duncan, S. B. Borgia, and D. E. Low. 1999. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob. Agents Chemother. 43:2144-2147.
15. de Azavedo, J. C., M. McGavin, C. Duncan, D. E. Low, and A. McGeer. 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B Streptococcus isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45:3504-3508.
16. Desjardins, M., K. L. Delgaty, K. Ramotar, C. Seetaram, and B. Toye. 2004. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J. Clin. Microbiol. 42:5620-5623.
17. Duarte, R. S., O. P. Miranda, B. C. Bellei, M. A. Brito, and L. M. Teixeira. 2004. Phenotypic and molecular characteristics of Streptococcus agalactiae isolates recovered from milk of dairy cows in Brazil. J. Clin. Microbiol. 42:4214-4222.
18. Duarte, R. S., B. C. Bellei, O. P. Miranda, M. A. Brito, and L. M. Teixeira. 2005. Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources. Antimicrob. Agents Chemother. 49:97-103.
19. Farley, M. M., R. C. Harvey, T. Stull, J. D. Smith, A. Schuchat, J. D. Wenger, and D. S. Stephens. 1993. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N. Engl. J. Med. 328:1807-1811.
20. Fluegge, K., S. Supper, A. Siedler, and R. Berner. 2004. Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany. Antimicrob. Agents Chemother. 48:4444-4446.
21. Gherardi, G., M. Imperi, L. Baldassarri, M. Pataracchia, G. Alfarone, S. Recchia, G. Orefici, G. Dicuonzo, and R. Creti. 2007. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J. Clin. Microbiol. 45:2909-2916.
22. Gonzalez, J. J., and A. Andreu. 2005. Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain. Antimicrob. Agents Chemother. 49:2525-2527.
23. Gonzalez Pedraza Aviles, A., M. C. Ortiz Zaragoza, and R. Mota Vazquez. 2002. Serotypes and antimicrobial susceptibility of group B Streptococcus from pregnant women in Mexico. Rev. Latinoam. Microbiol. 44:133-136.
24. Hsueh, P. R., L. J. Teng, L. N. Lee, S. W. Ho, P. C. Yang, and K. T. Luh. 2001. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob. Agents Chemother. 45:3205-3208.
25. Isenberg, H. D. 2004. Clinical microbiology procedures handbook, vol. 1, 2nd ed. ASM Press, Washington, DC.
26. Kaufmann, M. E. 1998. Pulsed-field gel electrophoresis, p. 33-51. In N. Woodford and A. P. Johnson (ed.), Molecular bacteriology: protocols and clinical applications. Humana Press Inc., Totowa, NJ.
27. Kong, F., S. Gowan, D. Martin, G. James, and G. L. Gilbert. 2002. Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes. J. Clin. Microbiol. 40:620-626.
28. Lachenauer, C. S., D. L. Kasper, J. Shimada, Y. Ichiman, H. Ohtsuka, M. Kaku, L. C. Paoletti, P. Ferrieri, and L. C. Madoff. 1999. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J. Infect. Dis. 179:1030-1033.
29. Lancefield, R. C., and E. H. Freimer. 1966. Type-specific polysaccharide antigens of group B streptococci. J. Hyg. (Lond.) 64:191-203.
30. Lee, K., J. W. Shin, Y. Chong, and H. Mikamo. 2000. Trends in serotypes and antimicrobial susceptibility of group B streptococci isolated in Korea. J. Infect. Chemother. 6:93-97.
31. Lopardo, H. A., P. Vidal, P. Jeric, D. Centron, H. Paganini, R. R. Facklam, and J. Elliott. 2003. Six-month multicenter study on invasive infections due to group B streptococci in Argentina. J. Clin. Microbiol. 41:4688-4694.
32. Luna, V. A., P. Coates, E. A. Eady, J. H. Cove, T. T. Nguyen, and M. C. Roberts. 1999. A variety of gram-positive bacteria carry mobile mef genes. J. Antimicrob. Chemother. 44:19-25.
33. Maione, D., I. Margarit, C. D. Rinaudo, V. Masignani, M. Mora, M. Scarselli, H. Tettelin, C. Brettoni, E. T. Iacobini, R. Rosini, N. D'Agostino, L. Miorin, S. Buccato, M. Mariani, G. Galli, R. Nogarotto, V. Nardi Dei, F. Vegni, C. Fraser, G. Mancuso, G. Teti, L. C. Madoff, L. C. Paoletti, R. Rappuoli, D. L. Kasper, J. L. Telford, and G. Grandi. 2005. Identification of a universal group B Streptococcus vaccine by multiple genome screen. Science 309:148-150.
34. Manning, S. D. 2003. Molecular epidemiology of Streptococcus agalactiae (group B Streptococcus). Front. Biosci. 8:s1-s18.
35. Martinez, M. A., A. Ovalle, C. Duran, I. Reid, G. Urriola, B. Garay, and M. Cifuentes. 2004. Serotypes and antimicrobial susceptibility of Streptococcus agalactiae. Rev. Med. Chil. 132:549-555.
36. Mollerach, A., E. Mendez, R. Massa, and J. Di Conza. 2007. Streptococcus agalactiae isolated in Santa Fe, Argentina: antibiotic susceptibility and erythromycin-clindamycin resistance mechanisms. Enferm. Infecc. Microbiol. Clin. 25:67-68.
37. Nagano, N., Y. Nagano, K. Kimura, K. Tamai, H. Yanagisawa, and Y. Arakawa. 2008. Genetic heterogeneity in pbp genes among clinically isolated group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. 52:4258-4267.
38. Paoletti, L. C., and D. L. Kasper. 2002. Conjugate vaccines against group B Streptococcus types IV and VII. J. Infect. Dis. 186:123-126.
39. Persson, E., S. Berg, B. Trollfors, P. Larsson, E. Ek, E. Backhaus, B. E. Claesson, L. Jonsson, G. Radberg, T. Ripa, and S. Johansson. 2004. Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001. Clin. Microbiol. Infect. 10:791-796.
40. Phares, C. R., R. Lynfield, M. M. Farley, J. Mohle-Boetani, L. H. Harrison, S. Petit, A. S. Craig, W. Schaffner, S. M. Zansky, K. Gershman, K. R. Stefonek, B. A. Albanese, E. R. Zell, A. Schuchat, and S. J. Schrag. 2008. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299:2056-2065.
41. Pillai, P., U. Srinivasan, L. Zhang, S. M. Borchardt, J. Debusscher, C. F. Marrs, and B. Foxman. 2009. Streptococcus agalactiae pulsed-field gel electrophoresis patterns cross capsular types. Epidemiol. Infect. 137:1420-1425.
42. Poyart, C., L. Jardy, G. Quesne, P. Berche, and P. Trieu-Cuot. 2003. Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob. Agents Chemother. 47:794-797.
43. Puopolo, K. M., D. C. Klinzing, M. P. Lin, D. L. Yesucevitz, and M. J. Cieslewicz. 2007. A composite transposon associated with erythromycin and clindamycin resistance in group B Streptococcus. J. Med. Microbiol. 56:947-955.
44. Roberts, M. C., J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide- streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.
45. Schoening, T. E., J. Wagner, and M. Arvand. 2005. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany. Clin. Microbiol. Infect. 11:579-582.
46. Schrag, S., R. Gorwitz, K. Fultz-Butts, and A. Schuchat. 2002. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recommend. Rep. 51(RR-11):1-22.
47. Schuchat, A. 1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497-513.
48. Schuchat, A. 1999. Group B Streptococcus. Lancet 353:51-56.
49. Seppälä, H., M. Skurnik, H. Soini, M. C. Roberts, and P. Huovinen. 1998. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262.
50. Simões, J. A., V. M. Alves, S. E. Fracalanzza, R. P. de Camargo, L. Mathias, H. M. Milanez, and E. M. Brolazo. 2007. Phenotypical characteristics of group B Streptococcus in parturients. Braz. J. Infect. Dis. 11:261-266.
51. Slotved, H. C., S. Sauer, and H. B. Konradsen. 2002. False-negative results in typing of group B streptococci by the standard Lancefield antigen extraction method. J. Clin. Microbiol. 40:1882-1883.
52. Slotved, H. C., F. Kong, L. Lambertsen, S. Sauer, and G. L. Gilbert. 2007. Serotype IX, a proposed new Streptococcus agalactiae serotype. J. Clin. Microbiol. 45:2929-2936.
53. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
54. Teixeira, L. M., M. G. Carvalho, V. L. Merquior, A. G. Steigerwalt, D. J. Brenner, and R. R. Facklam. 1997. Phenotypic and genotypic characterization of Vagococcus fluvialis, including strains isolated from human sources. J. Clin. Microbiol. 35:2778-2781.
55. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
56. Tettelin, H., V. Masignani, M. J. Cieslewicz, C. Donati, D. Medini, N. L. Ward, S. V. Angiuoli, J. Crabtree, A. L. Jones, A. S. Durkin, R. T. Deboy, T. M. Davidsen, M. Mora, M. Scarselli, I. Margarit y Ros, J. D. Peterson, C. R. Hauser, J. P. Sundaram, W. C. Nelson, R. Madupu, L. M. Brinkac, R. J. Dodson, M. J. Rosovitz, S. A. Sullivan, S. C. Daugherty, D. H. Haft, J. Selengut, M. L. Gwinn, L. Zhou, N. Zafar, H. Khouri, D. Radune, G. Dimitrov, K. Watkins, K. J. O'Connor, S. Smith, T. R. Utterback, O. White, C. E. Rubens, G. Grandi, L. C. Madoff, D. L. Kasper, J. L. Telford, M. R. Wessels, R. Rappuoli, and C. M. Fraser. 2005. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome." Proc. Natl. Acad. Sci. U. S. A. 102:13950-13955.
57. Varaldo, P. E., M. P. Montanari, and E. Giovanetti. 2009. Genetic elements responsible for erythromycin resistance in streptococci. Antimicrob. Agents Chemother. 53:343-353.
58. Weisblum, B. 1985. Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression - a review. J. Antimicrob. Chemother. 16(Suppl. A):63-90.